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A tight control of Rif1 by Oct4 and Smad3 is critical for
mouse embryonic stem cell stability
P Li1,2,3, X Ma1,2, IR Adams4 and P Yuan*,1,2,3,5
Prolonged culture of embryonic stem cells (ESCs) leads them to adopt embryonal carcinoma cell features, creating enormous
dangers for their further application. The mechanism involved in ESC stability has not, however, been extensively studied. We
previously reported that SMAD family member 3 (Smad3) has an important role in maintaining mouse ESC stability, as depletion of
Smad3 results in cancer cell-like properties in ESCs and Smad3− /− ESCs are prone to grow large, malignant teratomas. To
understand how Smad3 contributes to ESC stability, we performed microarray analysis to compare the transcriptome of wild-type
and Smad3− /− ESCs. We found that Rif1 (RAP1-associated protein 1), a factor important for genomic stability, is significantly
upregulated in Smad3− /− ESCs. The expression level of Rif1 needs to be tightly controlled in ESCs, as a low level of Rif1 is
associated with ESC differentiation, but a high level of Rif1 is linked to ESC transformation. In ESCs, Oct4 activates Rif1, whereas
Smad3 represses its expression. Oct4 recruits Smad3 to bind to Rif1 promoter, but Smad3 joining facilitates the loading of a
polycomb complex that generates a repressive epigenetic modification on Rif1 promoter, and thus maintains the expression of Rif1
at a proper level in ESCs. Interestingly, Rif1 short hairpin RNA (shRNA)-transduced Smad3− /− ESCs showed less malignant
properties than the control shRNA-transduced Smad3− /− ESCs, suggesting a critical role of Rif1 in maintaining the stability of
ESCs during proliferation.
Cell Death and Disease (2015) 6, e1588; doi:10.1038/cddis.2014.551; published online 8 January 2015
Embryonic stem cells (ESCs) can serve as a rich source of
differentiated cells for cell-based therapy due to their
pluripotency and unlimited self-renewal capacity. However,
prolonged culture of ESCs results in ESCs accumulating
numerous mutations, and they gradually adopt embryonal
carcinoma cell features.1–3 This prompts serious safety
concerns with regard to ESC applications and also raises
important questions regarding how ESCs maintain their
genomic stability.
Transforming growth factor beta (TGF-β) signaling has an
important role in development and homeostasis. It also
functions in multiple diseases such as cancer, tissue fibrosis
and diabetes.4,5 Through their respective ligand receptors,
TGF-β/Activin/Nodal activates SMAD family member (Smad)
2/Smad3. The activated Smads bind to Smad4 and translo-
cate from cytoplasm to the nucleus to regulate the down-
stream genes.6,7 TGF-β/Activin/Nodal signaling is crucial for
maintaining self-renewal and pluripotency in human ESCs, but
appears to be dispensable for the pluripotency of mouse
ESCs.8,9 Instead, the activation of Activin/Nodal signaling is
required for the propagation of mouse ESCs.10,11 Smad3 is a
downstream factor of TGF-β/Activin/Nodal signaling. Although
depletion of Smad3 leads to transient expression distortion of
mesoderm markers during embryoid body (EB) formation,
the final lineage formation is not affected,12 as Smad3
knockout mice are viable and fertile.13 This may be because
Smad2, another downstream factor of TGF-β/Activin/Nodal
signaling, has a redundant role of Smad3. It has been
reported that Smad2 and Smad3 collaboratively regulate
mesoderm formation during embryo development.12,14
Previously, we found that activation of Smad3 is vitally
important for ESCs to maintain their genetic integrity during
propagation, as depletion of Smad3 leads mouse ESCs to
adopt cancer cell properties.12 To further illustrate how
Smad3 contributes to ESC stability, we performed microarray
assay to identify genes that show an obvious change after
Smad3 depletion. Among the genes affected by Smad3
depletion, Rif1 (RAP1-associated protein 1), a factor closely
associated with chromatin stability, shows the greatest
upregulation.
Rif1 is first identified in budding yeast as a Rap1-
interacting factor. It is recruited to the telomere by Rap1
and implicated in maintaining telomere structure and
homeostasis.15,16 In mammalian cells, except the regulation
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of telomere homeostasis,17,18 Rif1 mediates the ATM
(ataxia telangiectasia mutated)/53BP1 (tumor suppressor
p53-binding protein 1) signaling after DNA damage to repress
break resection and promote the non-homologous end joining
(NHEJ) mechanism in G1 phase.19–23 In addition, Rif1 globally
regulates the replication-timing program in both yeast fission
and mammalian cells.24–27 Rif1 localizes to the stalled
replication forks in response to ATR activation and serves as
a component of the DNA replication checkpoint.28–31 Rif1 is
also highly expressed in the pluripotent stem cells.32–34
Knockdown of Rif1 by RNA interference in mouse ESCs
leads to ESC differentiation.35
In this study, we determine that Rif1 is an important
contributor to ESC stability during its propagation. Rif1
expression level is tightly controlled by Smad3 and Oct4.
Reduction of Rif1 by RNA interference leads Smad3− /−
ESCs to show less malignant properties than control
shRNA knockdown Smad3− /− ESCs, suggesting that
upregulation of Rif1 is a key factor in the transformation of
Smad3− /− ESCs.
Results
Rif1 is a direct downstream target of Smad3. Previously,
we reported that depletion of Smad3 in mouse ESCs
produced cancer cell-like features.12 To understand the
underlying mechanism, cDNA microarray analysis was
performed to compare the transcriptome between wild-type
(WT) and Smad3− /− ESCs. Genes with more than a 1.5-
fold difference between WT and Smad3− /− ESCs were
selected by Partek software to generate a heat map. On the
basis of the microarray data, the expression of Smad3 and
Lefty1 was markedly reduced in Smad3− /− ESCs. Besides,
validation of eight randomly picked genes by real-time PCR
further suggests that the microarray result was reliable.
Among the genes that show different expression after Smad3
depletion, Rif1 ranked as the highest upregulated gene in
Smad3− /− ESCs (Figure 1a and Supplementary Figure S1A).
Real-time PCR and western blot analysis confirmed the
upregulation of Rif1 at both mRNA and protein level in
Smad3− /− ESCs (Figures 1b and c). Furthermore, over-
expression of Smad3 in Smad3− /− ESCs could significantly
downregulate Rif1 expression, but upregulate Lefty1 expres-
sion (Figure 1d). As Smad3 is a downstream factor of the
Activin pathway in mouse ESCs,10 we treated ESCs with
Activin A (25 ng/ml) and Activin A inhibitor SB431542
(10 μM), respectively, to examine the expression of Rif1.
As expected, the expression of Rif1 was decreased by Activin A
treatment, but increased by SB431542 treatment. The
expression of Lefty1 and Lefty2 was regulated conversely,
confirming that Lefty1 and Lefty2 are positively regulated by
Activin/Smad3 pathway, whereas Rif1 is negatively regulated
by this pathway (Figures 1e and f). On the basis of Mullen’s
chromatin immunoprecipitation (ChIP)-seq data, there are
two Smad3-binding sites (SBS1 and SBS2) at the promoter
region of Rif1.4 Therefore, we designed primers to quantitate
Rif1-1 and Rif1-2 regions that cover SBS1 and SBS2,
respectively. Examining ChIP-enriched DNA by real-time
PCR, we found that Smad3 specifically bound to the Rif1-1
and Rif1-2 regions (Figure 1g). To further examine whether
Rif1 promoter activity was affected by Smad3 depletion, a
luciferase assay was performed with the Rif1 promoter
containing the Smad3-binding sites. The result showed that
Rif1 promoter activity was enhanced in Smad3− /− ESCs
compared with WT ESCs (Figure 1h). Taken together, all
these data demonstrated that Rif1 is a target of the Activin/
Smad3 pathway, and that Smad3 represses Rif1 expression
in mouse ESCs.
Inverse expression profiles between Smad3 and Rif1. To
further examine the correlation between Smad3 and Rif1, we
examined the expression profiles of these two genes in
mouse ESCs, mouse embryonic fibroblasts (MEFs), teratoma
cells and mouse ESC-differentiated cells. Smad3 showed
higher expression in MEFs and teratoma cells than in ESCs.
Conversely, Rif1 was expressed at a lower level in MEFs
and teratoma cells than in ESCs (Supplementary Figures
S1B, S1C and S2A). In addition, we also traced the
expression changes of Smad3 and Rif1 during ESC
differentiation using monolayer culture and EB formation
(Supplementary Figures S1D and S2B). ESC differentiation
was accompanied by gradual downregulation of pluripotent
markers and expression of lineage markers (Supplementary
Figures S1E and S2C). During ESC differentiation, the
expression of Smad3 mRNA was gradually increased,
whereas the expression of Rif1 mRNA was decreased
(Supplementary Figures S1F and S2D). Interestingly,
although the expression of Rif1 was decreased in
Smad3− /− ESC-formed EBs, the Rif1 level was always
Figure 1 Smad3 represses Rif1 expression in ESCs. (a) The heat map shows the expression profile of genes with mRNA level increased or decreased for more than 1.5-fold
in Smad3− /− ESCs compared with WT ESCs. Lefty1 and Smad3 are decreased, whereas Rif1 is increased in Smad3− /− ESCs compared with WT ESCs. (b) Quantitative
real-time PCR to examine the mRNA level of Rif1 in WT and Smad3− /− ESCs. Actin was analyzed as an internal control. The data are shown as the mean±S.D. (n= 3).
(c) Western blot and densitometric analyses of the expression of Rif1 in WTand Smad3− /− ESCs. Gapdh expression level was used as an internal control. The data are shown
as the mean±S.D. (n= 2). (d) Western blot analysis of Smad3 (upper layer) and real-time PCR analysis of Lefty1 and Rif1 (lower layer) in pCAG-GFP- and pCAG-Smad3-
transfected Smad3− /− ESCs. Gapdh protein level and Actin expression level were used as internal controls for the western blot and real-time PCR analysis, respectively. Arrow
indicates the overexpression band of Flag-Smad3. The real-time PCR data are shown as the mean±S.D. (n= 3). (e) Quantitative real-time PCR to examine mRNA expression
levels of Lefty1, Lefty2 and Rif1 in mouse ESCs with Activin A (25 ng/ml) treatment for 0 and 24 h. Actin was analyzed as an internal control. The data are shown as the mean±S.D.
(n= 3). (f) Quantitative real-time PCR to examine mRNA expression levels of Lefty1, Lefty2 and Rif1 in mouse ESCs with SB431542 (10 μM) treatment for 0 and 24 h. Actin was
analyzed as an internal control. The data are shown as the mean± S.D. (n= 3). (g) ChIP-qPCR to examine Smad3 and IgG enrichment on the promoter of Rif1. The sketch of
Smad3-binding sites on the promoter of Rif1 has been indicated (SBS1 and SBS2), Rif1-1 and Rif1-2 regions cover SBS1 and SBS2, respectively. Protein enrichment on Actin
was analyzed as a control. The data are shown as the mean±S.D. (n= 3). (h) Luciferase assay to examine Rif1 promoter activity in WTand Smad3− /− ESCs at 48 h after
transfection. Two kb Rif1 promoter was cloned in front of firefly luciferase reporter. Renilla was analyzed as an internal control. The data are shown as the mean± S.D. (n= 3).
Statistically significant differences, calculated through student's t-tests, are indicated (*Po0.05; **Po0.01; ***Po0.001)
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higher in Smad3− /− ESC-formed EBs than in WT ESC-
formed EBs at the same stage, suggesting that Smad3 is one
of the key components regulating Rif1 expression during
ESC differentiation (Supplementary Figure S2E). These
expression profiles also confirm previous reports that Rif1 is
a factor associated with pluripotency.32,35
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Oct4 is required for Smad3 to bind to Rif1 promoter.
Multiple Oct4-bound genes are found to be co-occupied by
Smad3 and respond to TGF-β signaling.4 To find out whether
Rif1 is among these genes, we first knocked down the
expression of Pou5f1 by RNA interference. The expression
level of Rif1 was significantly decreased after Pou5f1 knock-
down (Figure 2a). This is consistent with the luciferase
activity of Rif1 promoter being reduced to 20% after Pou5f1
knockdown, suggesting that Rif1 is regulated by Oct4
(Figure 2b). Furthermore, overexpression of Pou5f1 in mouse
ESCs can enhance the expression of Rif1 at both mRNA and
protein level (Figures 2c and d). To determine whether Oct4
co-binds with Smad3 on Rif1 promoter region, we performed
ChIP assay with Oct4 antibody. As expected, Oct4 was highly
enriched on the promoter regions of Rif1 where Smad3 binds
(Figure 2e). These data support previous reports that Oct4
positively regulates Rif1 expression in mouse ESCs.33,35
Through co-immunoprecipitation and sequential ChIP
experiments, Mullen et al.4 discovered that Oct4 can form a
complex with Smad3 and recruit Smad3 to a Lefty1 enhancer
to regulate Lefty1 expression in mouse ESCs. Prompted by
the opposed regulatory roles of Smad3 and Oct4 on Rif1, we
first examined whether Smad3 is required for Oct4 to bind to
Rif1 promoter. As the Oct4 protein level is similar in WT and
Smad3− /− ESCs,12 we directly performed a ChIP assay with
Oct4 antibody. We found that Oct4 enrichment on Lefty1,
Lefty2 and Rif1 in WT and Smad3− /− ESCs was not
obviously affected by the depletion of Smad3 (Figure 2f). We
then investigated whether Oct4 is required for recruiting
Smad3 to bind to Rif1. We knocked down Pou5f1 by shRNA.
After 1-day selection with puromycin, the mRNA level of
Pou5f1 was significantly reduced, but the expression of
Smad3, pluripotent marker Nanog, lineage markers Cdx2,
Cxcr4 and T were not significantly changed and ESCs
still maintained the colony morphology (Supplementary
Figure S3A). Meanwhile, the Oct4 protein level was obviously
decreased, whereas the Smad3 was not affected
(Supplementary Figure S3B). We performed ChIP assay with
Smad3 antibody using cells at this stage and found that the
binding efficiency of Smad3 on Lefty1, Lefty2 and Rif1 was
significantly reduced after Pou5f1 knockdown (Figure 2g). To
further confirm that Oct4 and Smad3 co-bind to Rif1 promoter,
we performed re-ChIP assaywith a Smad3 antibody after Oct4
ChIP and discovered that Smad3 and Oct4 do bind to Rif1
promoter simultaneously (Figure 2h). These data suggested
that Oct4 is required for Smad3 to bind to Rif1 promoter, but
Smad3 is not required for Oct4 binding.
Rif1 promoter shows Smad3-dependent H3K27 methyla-
tion. Mullen et al.4 reported that Activin could induce both
upregulation and downregulation of the expression of Oct4
and Smad3 co-occupied genes, indicating that Oct4 and
Smad3 regulate their targets by sophisticated regulatory
mechanisms. To uncover how Oct4 and Smad3 regulate Rif1,
we performed the ChIP assay with histone modification
markers, H3K9me2, H3K9me3, H3K4Me3 and H3K27Me3.
H3K9me2 and H3K9me3 label the heterochromatin and
H3K4me3 and H3K27me3 are the bivalent markers that label
genes related to pluripotency and differentiation.36–38 Rif1
promoter was enriched by H3K4me3 and H3K27me3, but not
by H3K9me2 and H3K9me3 (Figures 3a and d). Depletion of
Smad3 did not affect H3K4me3 enrichment (Figure 3c), but
seriously affected H3K27me3 enrichment. However,
H3K27me3 level at Lefty1 and Lefty2 was not obviously
affected after Smad3 depletion (Figure 3d). This result
implies that Rif1 expression is controlled by a specific
epigenetic modification involving Smad3. As Suz12 is the
key component of the polycomb repressive complex (PRC2)
and contributes to H3K27me3, we performed a ChIP assay
with a Suz12 antibody. We found that Suz12 enrichment on
Rif1 is significantly reduced after Smad3 depletion, but its
enrichment on Lefty1 and Lefty2 was stable (Figure 3e).
Taken together, these data suggest that, although Oct4 and
Smad3 co-bind to Lefty1, Lefty2 and Rif1, the mechanism
used to regulate Rif1 is different to that used to regulate
Lefty1 and Lefty2. In the Rif1 regulatory complex, Smad3 has
a critical role in loading PRC2 to regulate the expression of
Rif1 through H3K27 methylation.
Smad3− /− ESCs show higher cell proliferation and DNA
repair capacities than WT ESCs after ultraviolet irradia-
tion. Our previous studies showed that Smad3 depletion
enhanced the anti-apoptosis capacity of ESCs. To further
substantiate this observation, we set out to examine the
response of WT and Smad3− /− ESCs to DNA damage in
detail. Before ultraviolet (UV) irradiation, WTand Smad3− /−
ESCs showed no obvious difference after propidium iodide
(PI) staining. Further, labeling the cells with bromodeoxyur-
idine (BrdU) revealed that more Smad3− /− ESCs showed
active DNA replication than WT ESCs. WT and Smad3− /−
ESCs were then exposed to UV irradiation (40mJ/cm2) to
induce DNA damage. Five hours later, the cells were pulse
labeled with BrdU and cultured for another 30min. Subse-
quently, the cells were collected and stained with PI and
FITC-conjugated BrdU antibody for flow cytometry analysis.
About 7% Smad3− /− ESCs showed active DNA replication
compared with only about 3% for the WT cells (Figures 4a
and b). This result demonstrated that Smad3− /− ESCs
have a higher cell proliferation capacity than WT ESCs after
DNA damage.
In responding to the DNA damage after UV irradiation, ATR-
Chk1 and ATM-Chk2 are activated to modulate checkpoint,
DNA repair, apoptosis and cell senescence. Replication
protein A (RPA) is an ssDNA-binding protein in eukaryotes
and prevents ssDNA from forming hairpin structures or
re-annealing when the DNA is under repair, replication or
recombination.39–42 RPA is upregulated after DNA damage
and it is essential for the ATR-mediated DNA damage
checkpoint.43,44 Smad3− /− ESCs expressed a significantly
higher level of RPA than WT ESCs at 1 h and 3 h after UV
irradiation (Figure 4c). Consistent with this, phosphorylated
Chk1 was significantly higher in Smad3− /− ESCs than WT
ESCs, whereas phosphorylated Chk2 was only slightly
increased in Smad3− /− ESCs (Figure 4d). These data imply
an elevated DNA damage response in Smad3− /− ESCs.
H2AX, a histone H2A variant, is phosphorylated by ATM
after DNA damage. It binds to the damaged DNA and attracts
more proteins to join the DNA repair, thus it is a good indicator
of DNA damage.45–48 Significant amounts of H2AX were
detected in both WT and Smad3− /− ESCs 1 h after UV
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Figure 2 Oct4 positively regulates Rif1 and is indispensable for Smad3 to bind to Rif1 promoter regions. (a) Quantitative real-time PCR to examine the mRNA levels of Pou5f1
and Rif1 after transfection with pSuper control and pSuper-Pou5f1-shRNA plasmids. Actin was analyzed as a control. The data are shown as the mean± S.D. (n= 3).
(b) Luciferase assay to examine Rif1 promoter activity in mouse ESCs transfected with pSuper control and pSuper-Pou5f1-shRNA plasmids. Renilla was analyzed as an internal
control. The data are shown as the mean±S.D. (n= 3). (c) Quantitative real-time PCR to examine the mRNA levels of Pou5f1, Lefty1 and Rif1 after transfection with pCAG-GFP
and pCAG-Pou5f1 plasmids. Actin was analyzed as a control. The data are shown as the mean±S.D. (n= 3). (d) Western blot analysis of the protein levels of Oct4 and Rif1 in
mouse ESCs transfected with pCAG-GFP and pCAG-Pou5f1 plasmids. Gapdh was analyzed as a control. Arrow indicates the overexpression band of Flag-Oct4. (e) ChIP-qPCR
to examine the DNA enrichment of Oct4 and control IgG at the Smad3-binding sites on the promoter of Rif1 in mouse ESCs. Enrichment of studied proteins on Actin was analyzed
as a control. The data are shown as the mean± S.D. (n= 3). (f) ChIP-qPCR to examine the Oct4 enrichment at the Lefty1, Lefty2 and Rif1 in WTand Smad3− /− ESCs. Actin
was analyzed as a control. The data are shown as the mean± S.D. (n= 3). (g) ChIP-qPCR to examine Smad3 enrichment at the Lefty1, Lefty2 and Rif1 at 1-day puromycin
selection after mouse ESCs were transfected with pSuper control and pSuper-Pou5f1-shRNA plasmids. Smad3 enrichment at Actin was analyzed as a control. The data are
shown as the mean±S.D. (n= 3). (h) Sequential ChIP assay was performed to examine Smad3 and IgG enrichment on Oct4-enriched DNAs. The quantity of enriched Lefty1,
Lefty2 and Rif1 (Rif1-1 and Rif1-2) fragments was checked by real-time PCR. The data are shown as the mean±S.D. (n= 3). Statistically significant differences, calculated
through student's t-tests, are indicated (*Po0.05; **Po0.01; ***Po0.001)
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irradiation, suggesting substantial DNA damage in these cells
(Supplementary Figure S5A). However, 6 h after UV irradiation,
phosphorylated H2AX was significantly less in Smad3− /−
ESCs than WT ESCs (Figure 4e), indicating that, at this point
in time, less-damaged DNA remained in the Smad3− /−
ESCs. All these observations confirm that Smad3− /− ESCs
have an enhanced DNA repair ability after UV irradiation. Rif1
has been demonstrated to be highly associated with
UV-induced DNA damage response and checkpoint
activation.30,48 We analyzed the phosphorylation level of
Chk1 in Smad3− /− ESCs after being transfected with Rif1
shRNA and treated with UV irradiation. Phosphorylated Chk1
was significantly reduced in the Rif1 knockdown Smad3− /−
ESCs compared with the control knockdown Smad3− /−
ESCs (Supplementary Figure S5B), suggesting that upregula-
tion ofRif1 in Smad3− /− ESCs mediates the enhanced DNA
damage response after UV irradiation.
Reduced cell proliferation by knockdown of Rif1 in
Smad3− /− ESCs. To check whether the upregulation of
Rif1 is a major factor for Smad3− /− ESC-enhanced
proliferation, two shRNAs targeting to two different regions
of Rif1 gene were constructed. Both of them could efficiently
reduce Rif1 at both mRNA and protein level. Knockdown of
Rif1 caused ESC differentiation with downregulation of
pluripotent markers alkaline phosphatase (AP) and Oct4
and upregulation of differentiation markers Cdx2, Gata6,
T and Fgf5 (Supplementary Figures S4A–S4D). Next we
transfected Rif1 shRNA into the Smad3− /− ESCs. We
found that the expression level of Rif1 in Smad3− /− ESCs
could be reduced to about the Rif1 level in WT ESCs by Rif1
shRNA after selection with puromycin for 3 days (Figures 5a
and b). To constantly reduce Rif1 expression in Smad3− /−
ESCs, we transduced Smad3− /− ESCs with lentivirus to
stably express Rif1 shRNA. By picking a number of single-
cell colonies, we were able to select Smad3− /− ESCs with
stably reduced Rif1. Rif1 shRNA-transduced Smad3− /−
ESCs expressed significantly lower Rif1 than Smad3− /−
ESCs and control shRNA-transduced Smad3− /− ESCs, but
a similar level of Rif1 to WT ESCs (Figure 5c). These Rif1
shRNA-transduced Smad3− /− ESCs could still proliferate.
The expression of Ccnd2 (cyclin-D2), which is increased in
Smad3− /− ESCs,12 was significantly decreased by Rif1
reduction (Figure 5d). Besides, BrdU integration assay
revealed that proliferating cell number in Rif1 knockdown
Smad3− /− ESCs was significantly reduced to about the WT
ESC level (Figures 5e and f), suggesting that upregulation of
Figure 3 Rif1 promoter shows Smad3-dependent H3K27 methylation ChIP-qPCR to examine (a) H3K9me2, (b) H3K9me3, (c) H3K4Me3, (d) H3K27Me3 and (e) Suz12
enrichment at Lefty1 and Lefty2 enhancer and Rif1 promoter in WT and Smad3− /− ESCs. Enriched Actin was analyzed as a negative control. The data are shown as the
mean± S.D. (n= 3). Statistically significant differences, calculated through student's t-tests, are indicated (*Po0.05; **Po0.01; ***Po0.001)
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Figure 4 Smad3− /− ESCs show enhanced cell proliferation and DNA repair capacity after UV irradiation. (a) Representative flow cytometry dot plot of BrdU-integrated WT
(WT1 and WT2) and Smad3− /− (Smad3− /− 1 and Smad3− /− 2) ESCs at 0 and 6 h after UV irradiation. x axis represents DNA content through PI stain and y axis
represents BrdU-FITC-labeled cells. (b) Statistical analysis of the BrdU-positive cell percentage of a from two independent experiments. The data are shown as the mean± S.D.
(n= 2). (c) Western blot and densitometric analyses of the expression of RPA2 in WT (WT1 and WT2) and Smad3− /− (Smad3− /− 1 and Smad3− /− 2) ESCs before, and
at 1 and 3 h after, UV (40 mJ/cm2) irradiation. Gapdh expression level was used as an internal control. The densitometric data are shown as the mean± S.D. (n= 2). (d) Western
blot and densitometric analyses of the expression of pChk1 (Ser345) and pChk2 (Thr68) in WT (WT1 and WT2) and Smad3− /− (Smad3− /− 1 and Smad3− /− 2) ESCs
before, and at 1 and 3 h after, UV (40 mJ/cm2) irradiation. Gapdh expression level was used as an internal control. The densitometric data are shown as the mean± S.D. (n= 2).
(e) Western blot and densitometric analyses of the expression of pH2AX (Ser139) in WT (WT1 and WT2) and Smad3− /− (Smad3− /− 1 and Smad3− /− 2) ESCs before,
and at 6 h after, UV (40 mJ/cm2) irradiation. Gapdh expression level was used as an internal control. The data are shown as the mean±S.D. (n= 2). Statistically significant
differences, calculated through student's t-tests, are indicated (*Po0.05; **Po0.01; ***Po0.001)
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Figure 5 Knockdown of Rif1 in Smad3− /− ESCs can attenuate cell proliferation. (a) Morphological appearances of WT ESCs, Smad3− /− ESCs and control shRNA- and
Rif1 shRNA-transduced Smad3− /− ESCs. Scale bar= 200 μm. (b) Quantitative real-time PCR to examine the mRNA level of Rif1 in WT ESCs and Smad3− /− ESCs after
being transfected with control shRNA and Rif1 shRNA plasmids. Actin was analyzed as an internal control. The data are shown as the mean± S.D. (n= 3). (c) Western blot and
densitometric analyses of the expression of Rif1 in WT, Smad3− /− ESCs and control shRNA- and Rif1 shRNA-transduced Smad3− /− ESCs. Gapdh expression level was
used as an internal control. The data are shown as the mean± S.D. (n= 2). (d) Quantitative real-time PCR to examine the mRNA level of Ccnd2 in WT ESCs and control shRNA-
and Rif1 shRNA-transduced Smad3− /− ESCs. Actin was analyzed as an internal control. The data are shown as the mean± S.D. (n= 3). Statistically significant differences,
calculated through student's t-tests, are indicated (*Po0.05; **Po0.01; ***Po0.001). (e) Immunofluorescence staining with BrdU antibody to examine BrdU integration in WT
ESCs and control shRNA- and Rif1 shRNA-transduced Smad3− /− ESCs. Cells were pulse labeled with BrdU for 30 min, and then fixed for BrdU staining. The nuclei were
stained with DAPI. Scale bar= 200 μm. (f) Flow cytometry analysis of BrdU integration percentage (pulse labeled with 30 min) in WT, control shRNA- and Rif1 shRNA-transduced
Smad3− /− ESCs. x axis represents BrdU-FITC cell percentage and y axis represents cell counts
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Rif1 in Smad3− /− ESCs is one of the main factors
enhancing ESC proliferation.
The cell migration capacity of Smad3− /− ESC-
differentiated cells is reduced by knockdown of Rif1.
Smad3− /− ESC-differentiated cells show enhanced cell
migration.12 To examine whether upregulation of Rif1
contributes to cell migration (Supplementary Figure S6A),
we performed wound-healing and transwell assays. After
induction of ESC differentiation by withdrawing 2i and
leukemia inhibitory factor (LIF), a wound scratch was
generated. Three hours after the scratch, there was no
obvious difference in the wound gap between control and Rif1
shRNA-transduced Smad3− /− ESC-differentiated cells. But
at 12 h after the scratch, the wound gap of the control sample
was narrower than Rif1 knockdown sample, suggesting a
reduced cell migration capacity caused by Rif1 knockdown.
This difference was more obvious at 24 h (Figure 6a). In
addition, a transwell assay also revealed that Rif1 knockdown
Smad3− /− ESC-differentiated cells had lower migration
capacity than the control (Supplementary Figure S6B). This is
consistent with the cell migration markers Mmp2 and Mmp9
being significantly downregulated in Rif1 knockdown
Smad3− /− ESC-differentiated cells compared with the
control knockdown samples (Supplementary Figure S6C).
Rif1 shRNA-transduced Smad3− /− ESCs form less-
malignant teratomas. To investigate whether upregulation
of Rif1 is responsible for Smad3− /− ESCs forming
malignant teratoma, we subcutaneously injected WT,
Smad3− /− ESCs and Rif1 shRNA-transduced Smad3− /−
ESCs into SCID mice. Four weeks later, all the injected ESCs
had formed tumors. Smad3− /− ESCs formed the largest
tumors and Rif1 shRNA-transduced Smad3− /− ESCs
formed the smallest tumors (Figure 6b). The same result
was obtained by a repeat injection assay. Hematoxylin
and eosin staining revealed that all these tumors were
teratomas with tissues of three germ layers (Supplementary
Figure S6D). Genotyping of tumor samples confirmed the
integration of Rif1 shRNA in the teratoma cells produced by
Rif1 shRNA-transduced Smad3− /− ESCs (Figure 6c).
Furthermore, the cell proliferation gene Ccnd2 and cell
migration genes Mmp2 and Mmp9 were significantly
reduced in the teratomas formed by Rif1 shRNA-
transduced Smad3− /− ESCs compared with the teratoma
formed by control Smad3− /− ESCs (Figure 6d). Staining
the teratomas with proliferating cell nuclear antigen (PCNA)
antibody showed that Smad3− /− ESC-formed teratomas
contained more PCNA-positive cells than WT ESC and Rif1
shRNA-transduced Smad3− /− ESC-formed teratomas
(Figures 6e and f). Collectively, these results demonstrated
that upregulation of Rif1 is one of the main factors in
Smad3− /− ESC transformation.
Discussion
In this study, we found that Rif1, a factor involved in genomic
stability, is tightly regulated by Oct4 and Smad3 in mouse
ESCs. Oct4 recruits Smad3 to theRif1 promoter and facilitates
the loading of the PRC2. To maintain Rif1 expression at a
proper level in ESCs, Oct4 activates Rif1 expression, but
Smad3 is involved in repressing it (Figure 7). Mullen et al.
reported that Nanog, Oct4 and Sox2 form a complex and tend
to co-bind with Smad3 on many genes. From the ChIP-seq
data of their report, we found that Nanog, Oct4 and Sox2 all
bind to the SBE of Rif1.4 It is therefore likely that Rif1 is
synergistically regulated by these core transcription factors in
ESCs. From past reports and our own studies, it seems very
important to keep Rif1 expressed at a suitable level to sustain
ESC pluripotency and stability. Low level of Rif1 leads to
mESC differentiation.35 However, high level of Rif1 is also
deleterious to ESCs by driving malignant transformation of
Smad3− /− ESCs. Comparison of the expression of Smad3
and Rif1 between teratoma cells and teratocarcinoma cell
lines F9 and P19 revealed that Smad3 was significantly lower
in teratocarcinoma cells than teratoma cells, whereas Rif1 is
significantly higher in teratocarcinoma cells than teratoma
cells (Supplementary Figures S7A and S7B). These data
support our findings and indicate that a disturbance in the
expression of Smad3 and Rif1 may be one of the underlying
mechanisms for teratocarcinoma formation.
It is reported that Rif1 colocalizes with DNA double-strand
breaks (DSBs) and is involved in DNA repair.48 Recent studies
revealed that Rif1 contributes to the inhibition of 5′ end
resection of DSBs, the first step of homologous recombination
(HR). As a result, NHEJ, an error-prone DNA repair is
promoted with Rif1 presence. In the absence of Rif1, the level
of misjoined chromosomes is significantly reduced.20,21,23,49
NHEJ leads to more chromatin instabilities, such as deletions,
translocations and amplifications, than HR. Chromatin
instability is closely linked to cancer cell formation as it
enables rapid evolution of cell subclones that show enhanced
proliferation, migration and resistance to drug treatment.50
Owing to the important role of Rif1 in NHEJ, it is not surprising
that it acts as an anti-apoptosis factor and is linked with tumor
formation.51–53 The Rif1 level is found to be significantly
increased in the breast cancer cells and depletion of Rif1
makes them more sensitive to drug treatment.51 Here we
observed that Rif1 is highly upregulated in Smad3− /− ESCs,
which also adopt some cancer cell-like properties. Upregula-
tion of Rif1 leads to enhanced DNA repair, most likely through
NHEJ. Therefore, the chromatin of Smad3− /− ESCs may be
more unstable than WT ESCs and knockdown of Rif1 in
Smad3− /− ESC may just slow down the pace of the
cells from evolving into more malignant cells. It has been
found that Rif1 depletion can sensitize cancer cells
to drug treatment with enhanced apoptosis.51 Recent study
revealed that Rif1 is important in maintaining the telomere
stability in ESCs as it can repress Zscan4, which can
trigger hyper-telomere elongation and cell senescence from
an elevated expression.18 Interestingly, the Rif1 shRNA-
transduced Smad3− /− ESCs formed smaller teratomas
than WT and Smad3− /− ESCs. This might be because the
constant expression of shRNA of Rif1 triggers apoptosis and
cell senescence. On the basis of these results, it is worthwhile
investigating whether control of Rif1 levels by drugs could
benefit the treatment of teratocarcinoma.
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Materials and methods
Cell culture and differentiation. Derivation of WTand Smad3− /− mouse
ESCs was described in previous reports.12,54 The ESCs were maintained on
feeders under the normal ESC medium, which is composed of DMEM with high
glucose (Gibco, Life Technologies, Grand Island, NY, USA) supplemented with 15%
ES culture grade FBS (Gibco), 0.1 mM non-essential amino acids (NEAA; Gibco),
0.1 mM 2-mercaptoethanol (Gibco), 2 mM glutamine (Gibco), 100 U/ml penicillin and
streptomycin (Gibco) and 1000 U/ml LIF (Millipore, Billerica, MA, USA). To obtain feeder-
free ESC lines, ESCs were passaged 2–3 times to completely get rid of the feeder
cells and grown on a 0.2% gelatin (Sigma, St. Louis, MO, USA)-coated dish in ES
medium containing LIF and 2i (1 μM PD325901 and 3 μM CHIR99021).
For ESC differentiation assay, 2i and LIF were removed and 1 μM retinoic acid
(RA) was added in the culture medium to induce ESC differentiation. For EB formation
assay, monolayer undifferentiated WT ESCs and Smad3− /− ESCs were
Figure 6 Knockdown of Rif1 in Smad3− /− ESCs can attenuate cell migration. (a) Image (upper) and histogram (lower) of scratch wound healing of WT ESCs and control
shRNA- and Rif1 shRNA-transduced Smad3− /− ESC-differentiated cells at 3, 12 and 24 h after scratch. The data are shown as the mean±S.D. (n= 2). (b) Picture of SCID
mice with tumors at 4 weeks after WT ESCs, Smad3− /− ESCs and Rif1 shRNA-transduced Smad3− /− ESCs were subcutaneously injected into SCID mice. (c) Genotyping
of ES cell formed tumors to confirm Rif1 shRNA integration in Rif1 shRNA transduced Smad3− /− ES cells. (d) Quantitative real-time PCR to examine the mRNA levels of
Smad3, Rif1, Ccnd2,Mmp2 andMmp9 in tumors grown from WT ESCs, Smad3− /− ESCs and Rif1 shRNA-transduced Smad3− /− ESCs. Actin was analyzed as an internal
control. The data are shown as the mean±S.D. (n= 3). (e) Immunofluorescence staining with anti-PCNA antibody to examine PCNA expression in WT ESC, control Smad3− /
− ESC and Rif1 shRNA-transduced Smad3− /− ESC-formed teratomas. The nuclei were stained with DAPI. Scale bar= 200 μm. (f) Quantification of the PCNA-positive cell
percentage compared with DAPI in WT ESC, control Smad3− /− ESC and Rif1 shRNA transduced Smad3− /− ESC-formed teratomas. Statistically significant differences,
calculated through student's t-tests, are indicated (*Po0.05; **Po0.01; ***Po0.001)
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trypsinized into single cells, and then seeded, at a density of 1 × 106 cells/10 ml, in a
10 cm non-adherent dish in ESC culture medium devoid of 2i and LIF. The culture
medium was changed every 2 days and the EBs collected on days 2, 4, 6, 8 and 10.
Plasmid constructs. Two shRNA constructs targeting Rif1 were generated
according to previous reports with pSuper.puro vector (Addgene, Cambridge, MA,
USA).35 To generate lentiviral vector for express shRNA by lentivirus, Rif1 shRNA
sequences together with the H1 promoter were cut from pSuper plasmid with EcoRI
and ClaI and sub-cloned to pLVTH plasmid. To construct the Rif1 promoter reporter
plasmid, a 2000 bp fragment, encompassing the Smad3-binding sites, was amplified
by primers from the genomic DNA of mouse ESCs and cloned into a pGL3 vector
(Promega, Madison, WI, USA) at the MluI and XhoI sites. To construct the pCAG-
GFP, pCAG-Smad3 and pCAG-Pou5f1 plasmids, the ORF sequences of these
genes were amplified from the cDNA of mouse ESCs, digested and inserted into
pCAG-Flag vector (Addgene) at BglII-XhoI (GFP and Smad3) and MluI-XhoI
(Pou5f1) sites. All the amplification primers have been added to Table 1 and these
recombinant vectors have been sequenced.
Real-time PCR assay. Real-time PCR analysis was conducted using the ABI
Prism 7900HT (Applied Biosystems, Foster City, CA, USA) analysis machine with
SYBR Premix Ex Taq (TaKaRa, Shiga, Japan) according to the manufacturer's
instructions. The cycle (CT) values of target genes were first normalized against the CT
value of an internal control (Actin gene) and then normalized against the CT value of
corresponding transcripts of the control sample. The DNA primer sequences used for
the real-time PCR assay are listed in Table 1. For each pair of the primer, only one
correct size band and one peak were detected. All the real-time PCR assays
comprised triplicate data with samples from three independent experiments.
Western blot. WT and Smad3− /− ESCs were collected with RIPA protein
lysis buffer, containing 0.2 M NaCl, 1% SDS, 1 mM PMSF inhibitor and 0.1 M DTT.
Then, the SDS-PAGE was used to separate the proteins. After separation, the
proteins were transferred to PVDF membranes (Pall Corporation, Port Washington,
NY, USA). Subsequently, the PVDF membranes were blocked in 5% nonfat milk (BD
Company, Franklin Lakes, NJ, USA) in TBS with 0.1% Tween-20 for 1 h at room
temperature and incubated with the primary antibody in TBS+0.1% Tween-20
overnight at 4 °C. The primary antibodies and the dilution ratios were as follows:
Mouse anti-Gapdh (A-3) (sc-137179; Santa Cruz Biotechnology, Santa Cruz, CA,
USA) used at 1/2000; Rabbit anti-Smad3 antibody (06–920, Upstate, Billerica, MA,
USA) used at 1/1000; Goat anti-Oct3/4 (N-19) (sc-8628; Santa Cruz Biotechnology)
used at 1/2000; Rif1 antibody (provided by Ian R Adams) used at 1/1000 dilution;
Anti-Replication Protein A (Ab-2) (RPA34-19) antibody (Millipore) used at a
concentration of 5 μg/ml; and Rabbit anti-pH2AX (Ser139, #2577), anti-pChk1
(Ser345, #2348) and anti-pChk2 (Thr68, #2661; Cell Signaling Technology, Denver,
MA, USA) used at 1/1000 dilution. After blotting with the primary antibody, the PVDF
membranes were washed with TBS+0.1% Tween 205 times, for 10 min each, and
then blotted with the proper secondary antibodies. The secondary antibodies were
anti-mouse immunoglobulin G (IgG)-HRP (Sant Cruz Biotechnology; Sc-2314) and
anti-Rabbit IgG-HRP (GE Healthcare Life Sciences Dako, Piscataway, NJ, USA) at
1/10000 dilutions for both. Eventually, the signals were tested using ECL detection
reagents (Abcam, Cambridge, UK).
Microarray. Total RNAs of WT ESCs and Smad3− /− cells were extracted using
Trizol (Invitrogen, Life Technologies) according to the manufacturer's instructions. Ten
μg of total RNAs was aliquoted and digested with DNAse (New England Biolaboratory,
Ipswich, MA, USA) at 37 °C for 45 min to remove DNA contamination, and then the
RNA samples were purified with a RNeasy mini-kit (Qiagen, Valencia, CA, USA)
according to the manufacturer's instructions. Subsequently, the purified RNAs were
transferred for reverse transcription, labeled and hybridized to an Affymetrix mouse
exon 1.0 STArray (Santa Clara, CA, USA) according to the manufacturer’s instructions.
The array data were analyzed using Partek Inc (St. Louis, MO, USA) and Genespring
software (Agilent Technologies Inc, Santa Clara, CA, USA). The threshold for gene
expression was 1.5-fold. The expression level of genes larger than 1.5-fold (up or
down) were picked out to draw the heat map. The GEO access number for the
microarray data is GSE57995.
ChIP assay. A ChIP assay for mouse ESCs was carried out as described
previously.55 Briefly, 1% (w/v) formaldehyde was added to 3 × 107 cells and
incubated at room temperature for 10 min, then inactivated by adding 125 mM
glycine for 5 min. The cells were then lysed and the chromatin fragmented by a
Bioruptor Sonicator (Bioruptor UCD-200, Diagenode Company, Liège, Belgium) to a
size around 500 bp. Soluble chromatins were incubated at 4 °C overnight with a
Dynabead (Invitrogen) coupled anti-Smad3 antibody (06–920, Upstate), anti-Oct3/4
(N-19) (sc-8628; Santa Cruz Biotechnology), anti-H3K9Me2 antibody (Milipore),
anti-H3K9Me3 antibody (Milipore), anti-H3K4Me3 antibody (Abcam), anti-
H3K27Me3 antibody (Milipore), anti-SUZ12 antibody (Abcam) or a corresponding
control IgG (Milipore). The antibody-enriched DNAs were decrosslinked and purified
with phenol–chloroform (Ambion, Applied Biosystems), followed by ethanol
precipitation. The precipitated DNA was dissolved in TE buffer and analyzed by
real-time PCR using the ABI Prism 7900HT sequence detection system and SYBR
Premix Ex Taq (TaKaRa). Fold enrichments of the enriched DNA were calculated
according to ratios of the immunoprecipitated DNA to the input samples and then
normalized against the DNA level at control regions. All the DNA primer sequences
used for the ChIP-qPCR assay are listed in Table 1. For each pair of the primer, only
one correct size band and one peak were detected. All the real-time PCR assays
comprised triplicate data with samples from three independent experiments.
Luciferase assay. For luciferase assay, the Renilla plasmid (5 ng per well) was
used as the internal transfection control, whereas the pGL3 empty vector (100 ng
Figure 7 Model for Rif1 regulation and function in ESCs
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per well) was used as the experimental control. Lipfectamine 2000 (Invitrogen) was
used to conduct transfection experiments following the manufacturer's instructions.
Forty-eight hours after transfection, luciferase activity was detected using a Dual-
Luciferase Reporter Assay System (Promega) according to the manufacturer's
instructions. Transfection of each pGL3 construct was performed in triplicate in each
assay and a total of three independent experiments were performed. Empty vector
(pGL3) was transfected to both WT and Smad3− /− ESCs in triplicate for
normalization. The luciferase readings were recorded and ratios of Renilla luciferase
readings to firefly luciferase readings were recorded for each experiment and
triplicate data averaged. The average values of the tested constructs were
normalized to the activity of the pGL3 empty construct and the Renilla activity. The
error bar represents mean± S.D. (n= 3).
AP stain. WTand Smad3− /− ESCs were washed with DPBS buffer (Dulbecco’s
phosphate-buffered saline, Invitrogen) and fixed with a solution containing 90%
methanol and 10% formaldehyde for 20 min at room temperature. The ESC samples
were then washed with DPBS buffer three times, each for 3 min. Subsequently, the
ESCs were incubated for 15 min in the dark chamber at room temperature with an AP
staining solution composed of solution A (0.4 mg/ml Fast Red Violet LB Base solution,
Sigma), solution B (4 mg/ml Napthol AS-BI phosphate solution, Sigma) and water, in a
ratio of 2 : 1 : 3, according to the manufacturer's instructions. Finally, the ESC samples
were washed with DPBS buffer three times, each for 3 min, and photographed with an
Olympus microscope (FV1000, Olympus, Tokyo, Japan).
BrdU integration and flow cytometry analysis. 3 × 105 WT ESCs and
Smad3− /− ESCs, respectively, were seeded on six-well plates in an ESC culture
medium for 2 days and then incubated in a serum-free ESC culture medium for one
night. The next morning, the medium was replaced with a thin layer of PBS buffer
and the cells were irradiated with UV (40 mJ cm− 2) using UV Stratalinker 2400
(Stratagene Company, Oceanside, CA, USA). After UV irradiation, the cells were
cultured in normal conditions (37 °C and 5% CO2) for another 3 h in ESC culture
medium containing serum. Thirty minutes before collecting the samples, then BrdU
(10 μM) was added in the medium for pulse integration. The WT ESCs and
Smad3− /− ESCs were then digested with 0.25% EDTA-trypsin to obtain single
cells, which were subsequently fixed in cold 70% ethanol, overnight at 4 °C. To
remove RNA contamination, WT and Smad3− /− ESC samples were treated with
100 μg/ml RNAse (Sigma) for 30 min at 37 °C. Next, the cells were stained with the
Alexa Fluor 488 conjugate anti-BrdU mouse monoclonal antibody (1 : 100,
Invitrogen) for 1 h at room temperature. Eventually, the cells were washed with
PBS and stained with 20 μg/ml PI solution (Sigma) at 37 °C for 1 h in a dark room.
Flow cytometric analysis was performed on 10,000 gated events using a FACS
Calubur (BD Biosciences, Becton Dickinson, Franklin Lakes, NJ, USA). The
software used to analyze the phase distribution of the cell cycle was FCS Express
V3 (De Novo Software Company, Los Angeles, CA, USA). The cell distribution ratio
data were collected and analyzed. All the data were duplicated.
Wound-healing assay and transwell assay. 4 × 105 WTand Smad3− /−
ESCs were seeded in six-well tissue culture plates, respectively, in 2i and LIF
ESC culture media. After 2 days, the ESC media were changed to differentiation media,
in which 2i and LIF were removed and 1 μM RA (Sigma) was added, for another day to
promote quick ESC differentiation. When ESCs were completely differentiated into
monolayer cells, autoclaved yellow pipette tips were used to generate scratches. After
scratching, the detached cells were removed by washing twice with DPBS buffer, and
then cultured in differentiation media for another 24 h under normal condition. Images
were taken by a Zeiss microscope (Carl Zeiss, Jena, Germany) and analyzed, using
Image J software (NIH, Washington, DC, USA), at 0 and 24 h. Triplicate independent
assays were performed. The cell invasive assay was performed using the CytoSelect
24-Well Cell Invasion Assay Kit (Cat # CBA-110-COL, Cell Biolabs, Inc., San Diego, CA,
USA) according to the manufacturer's instructions.
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Table 1 Primers used in the study
Real-time PCR primers
Actin F 5′-ACCAACTGGGACGACATGGAGA-3′
Actin R 5′-TACGACCAGAGGCATACAGGGAC-3′
Smad3 F 5′-CTGGGCCTACTGTCCAATGT-3′
Smad3 R 5′-CATCTGGGTGAGGACCTTGT-3′
Oct4 F 5′-AAGCCTGCCAGGAGCAAA-3′
Oct4 R 5′-ATCCGGCGTTATGCTGCTCT-3′
Nanog F 5′-GGCTATCTGGTGAACGCATCTGGAAG-3′
Nanog R 5′-AACTGTACGTAAGGCTGCAGAAAGTCCTC-3′
Rif1 F 5′-ACTGTCTCCACGGATGAAGA-3′
Rif1 R 5′-CAAATAGCTGGCTTCCAGTG-3′
Lefty1 F 5′-TGTGTGTGCTCTTTGCTTCC-3′
Lefty1 R 5′-GGGGATTCTGTCCTTGGTTT-3′
Lefty2 F 5′-CAGCCAGAATTTTCGAGAGGT-3′
Lefty2 R 5′-CAGTGCGATTGGAGCCATC-3′
Ccnd2 F 5′-AAGCCTGCCAGGAGCAAA-3′
Ccnd2 R 5′-ATCCGGCGTTATGCTGCTCT-3′
Cdx2 F 5′-CCTGCGACAAGGGCTTGTTTAG-3′
Cdx2 R 5′-TCCCGACTTCCCTTCACCATAC-3′
Pax6 F 5′-GCATGCAGAACAGTCACAGCGGA-3′
Pax6 R 5′-ACTCCCGTTTATACTGGGCTATTT-3′
Hand1 F 5′-GCCAAGGATGCACAAGCA-3′
Hand1 R 5′-GGGCTGCTGAGGCAACTC-3′
Fgf5 5′-GAGAGTGGTACGTGGCCCTGAACAAGAGAG-3′
Fgf5 5′-CTTCAGTCTGTACTTCACTGGGCTGGGACT-3′
T F 5′-CATCGGAACAGCTCTCCAACCTAT-3′
T R 5′-GTGGGCTGGCGTTATGACTCA-3′
Gata6 F 5′-TGCAAGATTGCATCATGACAGA-3′
Gata6 R 5′-TGACCTCAGATCAGCCACGTTA-3′
Sox17 F 5′-TTCTGTACACTTTAATGAGGCTGTTC-3′
Sox17 R 5′-TTGTGGGAAGTGGGATCAAG-3′
Cxcr4 F 5′-AGCATGACGGACAAGTACC-3′
Cxcr4 R 5′-GATGATATGGA AGCCTTACAC-3′
Mmp2 F 5′-ATGATGACATCAAGGGGATC-3′
Mmp2 R 5′-CGCCAAATAAACCGGTCCTT-3′
Mmp9 F 5′-GAGCTGTGCGTCTTCCCCTTC-3′
Mmp9 R 5′-GGAATGATCTAAGCCCAGTGC-3′
Eomes F 5′-CCTGGTGGTGTTTTGTTGTG-3′
Eomes R 5′-TTTAATAGCACCGGGCACTC-3′
Elf5 F 5′-CCCTCCTCCTCTTCAAAACC-3′
Elf5 R 5′-AAGTTGCCACAAGACCATCC-3′
Pdgfra F 5′-ACGTTCAAGACCAGCGAGTT-3′
Pdgfra R 5′-CGATCGTTTCTCCTGC CTTA-3′
CGA F 5′-GCCAGAGTGGAGAATCATAC-3′
CGA R 5′-AACTGAAGCGCGTCAGAAGT-3′
ChIP-qPCR primers
Actin F 5′-GTTACCCGGGATACTGACCT-3′
Actin R 5′-GGCACCACACCTTCTAC-3′
Lefty1 F 5′-GTAGCCAGCAGACAGGACAA-3′
Lefty1 R 5′-ATCCCCAATCCACATTCA-3′
Lefty2 F 5′-GCAATCTGCCCACTGTAAAA-3′
Lefty2 R 5′-TCGATCTTCCCAAGACTC-3′
Rif1-1 F 5′-CCAATTCTAGGCAGTTGCCT-3′
Rif1-1 R 5′-GGGAGTGTTGCTAAAGG-3′
Rif1-2 F 5′-ATCTCTGTGTTTGAGCACCC-3′
Rif1-2 R 5′-CGTGGAATCTTTCCGTCC-3′
shRNA sequences
Rif1 shRNA1 F 5′-GATCCCCGAACCGTATTCAGAATCAAttcaagagaTT
GATTCTGAATACGGTTCTTTTTA-3′
Rif1 shRNA1 R 5′-AGCTTAAAAAGAACCGTATTCAGAATCAAtctcttgaa
TTGATTCTGAATACGGTTCGGG-3′
Rif1 shRNA2 F 5′-GATCCCCGAGTACAATAAGTGTTGATttcaagagaATC
AACACTTATTGTACTCTTTTTA-3′
Rif1 shRNA2 R 5′-AGCTTAAAAAGAGTACAATAAGTGTTGATT
ctcttgaaaTCAACACTTATTGTACTCGGG-3′
Rif1 promoter primers
Rif1 F 5′-GTGGTCACGCGTTGTAGTTCTGAGTCTCTGG-3′
Rif1 R 5′-ACGTCACTCGAGGCTAGAGATGGGTGATGTA-3′
cDNA clone primers
GFP F 5′-ATACCGAGATCTATGGTGAGCAAGGGCGAGGAG-3′
GFP R 5′-ATACCCCTCGAGCTATCGAGATCTGAGTCCGGAC-3′
Smad3 F 5′-GTGGTCAGATCTATGTCGTCCATCCTGCCCT-3′
Smad3 R 5′-ACGTCACTCGAGCTAAGACACACTGGAACAGC-3′
Pou5f1 F 5′-GTGGTCACGCGTATGGCTGGACACCTGGCTT-3′
Pou5f1 R 5′-ACGTCACTCGAGTCAGTTTGAATGCATGGGAG-3′
Genotyping primers
pLvth-Rif1 shRNA F 5′-CGCTGACGTCATCAACCCGCTCCAAGGA-3′
pLvth-Rif1 shRNA R 5′-CGTATAATGTATGCTATACGAAG-3′
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